Trial Profile
CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2024
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms VA-IMPACT
- 05 Apr 2023 Status changed from not yet recruiting to recruiting.
- 12 Jan 2023 Planned End Date changed from 31 Dec 2028 to 31 Mar 2029.
- 12 Jan 2023 Planned primary completion date changed from 31 Dec 2028 to 31 Mar 2029.